Muszbek László

1.

Somodi, L., Horváth, E., Bárdos, H., Baráth, B., Pethő, D., Katona, É., Balla, J., Mutch, N. J., Muszbek, L.: Cellular FXIII in Human Macrophage-Derived Foam Cells.
Int. J. Mol. Sci. 24 (5), 1-12, (cikkazonosító: 4802), 2023.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2.

Somodi, L., Bekéné Debreceni, I., Kis, G., Cozzolino, M., Kappelmayer, J., Antal, M., Panyi, G., Bárdos, H., Mutch, N. J., Muszbek, L.: Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles.
J. Thromb. Haemost. 20 (5), 1223-1235, 2022.

doi DEA WoS Scopus

Folyóirat-mutatók:

D1 Hematology

D1 Medicine (miscellaneous)

3.

Raut, S., Katona, É., Riches-Duit, A., Coxon, C., Muszbek, L., Schroeder, V., Rigsby, P.: An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
J. Thromb. Haemost. 20 (2), 525-531, 2022.

doi DEA WoS Scopus

Folyóirat-mutatók:

D1 Hematology

D1 Medicine (miscellaneous)

4.

Csaba, B., Fésüs, L., Muszbek, L., Sipka, S.: Kesztyűs Lóránd kórélettan professzor, az 1951-ben függetlenné vált Debreceni Orvostudományi Egyetemnek dékánként első vezetője, majd kétszer (1959-1963, 1967-1973) annak rektora.
Gerundium. 13 (3-4), 22-53, 2022.

doi DEA

5.

Kissné Bogáti, R., Katona, É., Shemirani, A. H., Balogh, E., Bárdos, H., Jeney, V., Muszbek, L.: The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.
Int. J. Mol. Sci. 23 (10), 1-15, (cikkazonosító: 5845), 2022.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

6.

Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z. A., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203, 110-116, 2021.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Hematology

7.

Plamenova, I., Zolkova, J., Sokol, J., Kolkova, Z., Bereczky, Z., Katona, É., Muszbek, L., Kubisz, P., Staško, J.: Genetic Background of Inherited Factor XIII-A Subunit Deficiency: review of the Literature and Description of Two New Cases.
Semin. Thromb. Hemost. 47 (7), 885-889, 2021.

doi DEA

Folyóirat-mutatók:

Q1 Cardiology and Cardiovascular Medicine

Q1 Hematology

8.

Bovet, J., Hurják, B., Maistre, E. D., Katona, É., Pénzes-Daku, K., Muszbek, L.: Autoimmune Factor XIII Deficiency With Unusual Laboratory and Clinical Phenotype.
J. Thromb. Haemost. 18 (6), 1330-1334, 2020.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Hematology

D1 Medicine (miscellaneous)

9.

Hurják, B., Kovács, Z., Döncző, B., Katona, É., Haramura, G., Erdélyi, F., Shemirani, A. H., Sadeghi, F., Muszbek, L., Guttman, A.: N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence.
J. Thromb. Haemost. 18 (6), 1302-1309, 2020.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Hematology

D1 Medicine (miscellaneous)

10.

Pénzes-Daku, K., Hurják, B., Katona, É., Becs, G., Balla, J., Muszbek, L.: Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.
Int. J. Mol. Sci. 21, 1-15, 2020.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

11.

Kattula, S., Bagoly, Z., Tóth, N. K., Muszbek, L., Wolberg, A. S.: The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
J. Thromb. Haemost. 18 (4), 885-894, 2020.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Hematology

D1 Medicine (miscellaneous)

12.

Orosz, A., Csapó, A., Bagoly, Z., Székely, E. G., Tóth, E., Kovács, B., Bereczky, Z., Muszbek, L., Katona, É.: A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids.
J. Immunol. Methods. 471, 27-33, 2019.

doi DEA Scopus

Folyóirat-mutatók:

Q3 Immunology

Q2 Immunology and Allergy

13.

Orosz, Z. Z., Bárdos, H., Shemirani, A. H., Bekéné Debreceni, I., Lassila, R., Riikonen, A. S., Kremer Hovinga, J. A., Seiler, T. G., van Dorland, H. A., Schroeder, V., Boda, Z., Nemes, L., Früh Eppstein, B., Nagy, B., Facskó, A., Kappelmayer, J., Muszbek, L.: Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.
Int. J. Mol. Sci. 20 (23), 1-17, 2019.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

Q1 Spectroscopy

14.

Bagoly, Z., Muszbek, L.: Factor XIII: what does it look like?.
J. Thromb. Haemost. 17 (5), 714-716, 2019.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Hematology

D1 Medicine (miscellaneous)

15.

Balogh, G., Muszbek, L., Komáromi, I.: First Step of the Transglutaminase Reaction Catalyzed by Activated Factor XIII Subunit A, Hybrid Quantum Chemistry/Molecular Mechanics Calculations.
J. Phys. Chem. B. 123 (18), 3887-3897, 2019.

doi DEA

Folyóirat-mutatók:

Q1 Materials Chemistry

Q1 Medicine (miscellaneous)

Q1 Physical and Theoretical Chemistry

Q1 Surfaces, Coatings and Films

16.

Muszbek, L., Katona, É., Pénzes-Daku, K.: Antibodies against factor XIII subunits.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 17-21, 2017.

DEA

17.

Muszbek, L., Pénzes-Daku, K., Katona, É.: Auto-, and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences.
J. Thromb. Haemost. 16 (5), 822-832, 2018.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q1 Hematology

D1 Medicine (miscellaneous)

18.

Balogh, L., Katona, É., Mezei, Z. A., Kállai, J., Gindele, R., Édes, I., Muszbek, L., Papp, Z., Bereczky, Z.: Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Mol. Cell. Biochem. 448 (1-2), 199-209, 2018.

doi DEA

Folyóirat-mutatók:

Q3 Cell Biology

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

Q3 Molecular Biology

19.

Kovac, M., Mitic, G., Lalic-Cosic, S., Djordjevic, V., Tomic, B., Muszbek, L., Bereczky, Z.: Evaluation of endogenous thrombin potential among patients with antithrombin deficiency.
Thromb. Res. 166, 50-53, 2018.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Hematology

20.

Székely, E. G., Czuriga-Kovács, K. R., Bereczky, Z., Katona, É., Mezei, Z. A., Nagy, A. C., Tóth, N. K., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

doi DEA WoS Scopus

Folyóirat-mutatók:

D1 Multidisciplinary

21.

Muszbek, L., Pénzes-Daku, K., Katona, É., Kun, M., Bonnefoy, A., Vezina, Z., Szuber, N., Molnárné Rázsó, K., Bereczky, Z., Kerényi, A., Bécsi, B., Erdődi, F., Rivard, G. E.: Novel approach to the laboratory diagnosis of antibodies against coagulation factors, with special reference to antifactor XIII antibodies: SE2.4.
Clin. Chem. Lab. Med. 56 (9), 128-129, 2018.

DEA

22.

Katona, É., Muszbek, L.: The laboratory diagnosis of inherited FXIII deficiencies and the measurement of FXIII activity and antigen level.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 22-26, 2017.

DEA

23.

Selmeczi, A., Gindele, R., Ilonczai, P., Fekete, A., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Kovács, K. B., Bárdos, H., Ádány, R., Muszbek, L., Bereczky, Z., Boda, Z., Oláh, Z.: Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.
Thromb. Res. 158, 1-7, 2017.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Hematology

24.

Muszbek, L., Katona, É., Kerényi, A.: Assessment of Factor XIII.
In: Hemostasis and Thrombosis. Eds.: Emmanuel J. Favaloro, Giuseppe Lippi, Humana Press Inc., New York, 277-297, 2017. ISBN: 9781493971947

doi DEA

25.

Gindele, R., Selmeczi, A., Oláh, Z., Ilonczai, P., Pfliegler, G., Marján, E., Nemes, L., Nagy, Á., Losonczy, H., Mitic, G., Kovac, M., Balogh, G., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Boda, Z., Muszbek, L., Bereczky, Z.: Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center.
Thromb. Res. 160, 119-128, 2017.

doi DEA WoS Scopus

Folyóirat-mutatók:

Q2 Hematology

Teljes publikációs lista